Atovaquone-proguanil resistance in imported falciparum malaria in a young child

Pediatric Infectious Disease Journal

Volumn 27, Issue 6, 2008, Pages 567-569

  Rose, Gregory W ^a   Suh, Kathryn N ^a   Kain, Kevin C ^b   Saux, Nicole Le ^c   McCarthy, Anne E ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

Author keywords

Atovaquone proguanil; Cytochrome b; Malarone; Plasmodium falciparum; Resistance

Indexed keywords

ATOVAQUONE PLUS PROGUANIL; CLINDAMYCIN; CYTOCHROME B; QUININE; ANTIMALARIAL AGENT; ATOVAQUONE; ATOVAQUONE PROGUANIL; ATOVAQUONE-PROGUANIL; CYTOCHROME C; PROGUANIL;

ANTIBIOTIC RESISTANCE; ARTICLE; CASE REPORT; CHILD; CLINICAL EXAMINATION; DRUG EFFICACY; FOLLOW UP; GENE MUTATION; HUMAN; MALARIA; MALARIA FALCIPARUM; MALE; MOZAMBIQUE; PARASITEMIA; PRESCHOOL CHILD; PRIORITY JOURNAL; RELAPSE; TREATMENT FAILURE; ANIMAL; DRUG EFFECT; DRUG RESISTANCE; GENETICS; ISOLATION AND PURIFICATION; MISSENSE MUTATION; NORTH AMERICA; PARASITOLOGY; PLASMODIUM FALCIPARUM;

ANIMALS; ANTIMALARIALS; ATOVAQUONE; CHILD; CHLOROGUANIDE; CYTOCHROMES C; DRUG RESISTANCE; HUMANS; MALARIA, FALCIPARUM; MALE; MOZAMBIQUE; MUTATION, MISSENSE; NORTH AMERICA; PARASITEMIA; PLASMODIUM FALCIPARUM; TREATMENT FAILURE;

EID: 46249107108     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e318167918d     Document Type: Article

References (13)

1. Fivelman QL, Butcher GA Adagu IS, et al. Malarone treatment failure in in vitroconfirmation of resistance of Plasmodium falciparumisolate from Lagos, Nigeria. Malaria J.2002;1:1.
2. Färnert A, Lindberg J, Gil P, et al. Evidence of Plasmodium falciparummalaria resistant to atovaquone and proguanil hydrochloride: case reports. BMJ. 2003;326:628-629.
3. Schwartz E, Bujanover S, Kain KC. Genetic confirmation of atovaquone- proguanil-resistant Plasmodium falciparummalaria acquired by a nonimmune traveler to East Africa. Clin Infect Dis. 2003;37: 450 - 451.
4. David KP, Alifrangis M, Salanti A, et al. Atovaquone/proguanil resistance in Africa: a case report. Scand J Infect Dis. 2003;35:897- 898.
5. Wichmann O, Muehlberger N, Jelinek T, et al. Screening for mutations related to atovaquone/proguanil resistance in treatment failures and other imported isolates of Plasmodium falciparum. J Infect Dis. 2004;190: 1541-1546.
6. Kuhn S, Gill MJ, Kain KC. Emergence of atovaquone-proguanil resistance during treatment of Plasmodium falciparummalaria acquired by a non-immune North American traveler to West Africa. Am J Trop Med Hyg. 2005;72:407- 409.
7. Musset L, Bouchaud O, Matheron S, et al. Clinical atovaquone-proguanil resistance of Plasmodium falciparumassociated with cytochrome b codon 268 mutations. Microbes Infect. 2006;8:2599 -2604.
8. Legrand E, Demar M, Volney B, et al. First case of emergence of atovaquone resistance in Plasmodium falciparumduring second-line atovaquone-proguanil treatment in South America. Antimicrob Agents Chemother. 2007;51:2280 -2281.
9. Looaresuwan S, Viravan C, Webster HK, et al. Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand. Am J Trop Med Hyg. 1996;54:62- 66.
10. Srivastava IK, Vaidya AB. A mechanism for the synergistic antimalarial action of atovaquone and proguanil. Antimicrob Agents Chemother. 1999;43:1334 -1339.
11. Musset L, Pradines B, Parzy D, et al. Apparent absence of atovaquone/ proguanil resistance in 477 Plasmodium falciparumisolates from untreated French travellers. J Antimicrob Chemother. 2006;57:110 -115.
12. United Nation High Commissioner for Refugees. UNHCR Strategic Plan for Malaria Control 2005-2007. Geneva, Switzerland: United Nation High Commissioner for Refugees; 2006.
13. Musset L, Le Bras J, Clain J. Parallel evolution of adaptive mutations in Plasmodium falciparummitochondrial DNA during atovaquone-proguanil treatment. Mol Biol Evol. 2007;24:1582-1585.